Ketoconazole for Brain Cancer
Trial Summary
What is the purpose of this trial?
This trial is testing posaconazole, a drug usually used for fungal infections, to see if it can help treat brain tumors by stopping the tumor cells from growing. The study focuses on patients with limited treatment options for their brain tumors.
Will I have to stop taking my current medications?
The trial requires that you stop taking certain medications that interact with ketoconazole, such as some antibiotics, anti-seizure drugs, and medications for erectile dysfunction or pulmonary hypertension. If you are on these medications, you may need to switch to alternatives or stop them before joining the trial.
How does the drug ketoconazole differ from other treatments for brain cancer?
Ketoconazole is unique because it is an antifungal drug that has shown potential in treating certain cancers by inhibiting cell growth, although it is not a standard treatment for brain cancer. It works by blocking the synthesis of ergosterol, a key component of fungal cell membranes, and has been used in other conditions like prostate and breast cancer.12345
Eligibility Criteria
Adults with high-grade gliomas needing surgery can join this trial if they're in good enough health, can swallow pills, and have a life expectancy over 12 weeks. They must agree to use birth control and be able to follow the study plan. People who've had bad reactions to similar drugs, are pregnant or breastfeeding, have certain illnesses like hepatitis or psychiatric conditions that could affect participation, or take specific medications that interact with ketoconazole cannot participate.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Ketoconazole (Antifungal Agent)